Cancer is proving the most fatal disease nowadays, therefor profiling cancer is in the great demand. The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.
- Advertising -
Global Cancer Tumor Profiling Market By Technology, Technique, Application, Geography – Industry Trends and Forecast to 2024.
The global cancer tumor profiling market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request for Free Sample Visit @ databridgemarketresearch.com/reque…-profiling-market
Major Market Drivers and Restraints:
- Technological advancements for identifying the cancer tumors.
- Increasing the cancer incidences.
- Increase in the use of biomarkers in tumor profiling.
- Availability of Funding for Cancer Research
- Increase in demand for next generation sequencing technique in cancer profiling.
- Lack of Skilled Professionals and Infrastructure
- Growth in demand of personalized medicines
Key insights in-depth:
The global cancer tumor profiling market is highly fragmented and is based on new product launches and clinical results of products.
- Advertising -
Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global cancer tumor profiling market for global, Europe, North America, Asia Pacific and South America.
Market Segmentation by Types
The global cancer tumor profiling market is segmented by technology into next-generation sequencing, polymerase chain reaction, immunohistochemistry, in situ hybridization and microarray.
Read more about the Report Visit @ databridgemarketresearch.com/repor…profiling-market/
By Technique the market is segmented in genomics, proteomics, epigenetics and metabolomics.
By Application the market is segmented into personalized medicine, diagnostics, biomarker discovery, prognostics and research applications.
On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
In 2017, North America is expected to dominate the market.
Markets Top Key Players are:
tareIllumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.
For Any Query @ databridgemarketresearch.com/inqui…-profiling-market
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: